Conexeu Sciences Inc. Common Stock (NASDAQ:CNXU) — Market Cap & Net Worth
Market Cap & Net Worth: Conexeu Sciences Inc. Common Stock (CNXU)
Conexeu Sciences Inc. Common Stock (NASDAQ:CNXU) has a market capitalization of $213.26 Million ($213.26 Million) as of August 22, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #16399 globally and #3882 in its home market, demonstrating a 29.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Conexeu Sciences Inc. Common Stock's stock price $9.43 by its total outstanding shares 26758330 (26.76 Million). See CNXU equity financing ratio to understand what proportion of total assets are financed by equity.
Conexeu Sciences Inc. Common Stock Market Cap History: 2026 to 2026
Conexeu Sciences Inc. Common Stock's market capitalization history from 2026 to 2026. Data shows growth from $252.33 Million to $252.33 Million (0.00% CAGR). Also see CNXU total asset value for a full breakdown of the balance sheet.
Conexeu Sciences Inc. Common Stock Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Conexeu Sciences Inc. Common Stock's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check CNXU live share price for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of CNXU by Market Capitalization
Companies near Conexeu Sciences Inc. Common Stock in the global market cap rankings as of August 22, 2026. Also see Conexeu Sciences Inc. Common Stock (CNXU) cash conversion ratio for how efficiently the company converts equity into cash flow.
Key companies related to Conexeu Sciences Inc. Common Stock by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #187 globally with a market cap of $130.90 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #320 globally with a market cap of $83.19 Billion USD.
- CSL Ltd (AU:CSL): Ranked #466 globally with a market cap of $58.77 Billion USD ( AU$83.06 Billion AUD).
- Samsung Biologics Co Ltd (KO:207940): Ranked #556 globally with a market cap of $49.38 Billion USD ( ₩72.86 Trillion KRW).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #187 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $130.90 Billion | $540.26 |
| #320 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $83.19 Billion | $826.64 |
| #466 | CSL Ltd | AU:CSL | $58.77 Billion | AU$171.20 |
| #556 | Samsung Biologics Co Ltd | KO:207940 | $49.38 Billion | ₩1574000.00 |
Conexeu Sciences Inc. Common Stock Historical Marketcap From 2026 to 2026
Between 2026 and today, Conexeu Sciences Inc. Common Stock's market cap moved from $252.33 Million to $ 252.33 Million, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $252.33 Million | -- |
End of Day Market Cap According to Different Sources
On Aug 21st, 2026 the market cap of Conexeu Sciences Inc. Common Stock was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $213.26 Million USD |
| MoneyControl | $213.26 Million USD |
| MarketWatch | $213.26 Million USD |
| marketcap.company | $213.26 Million USD |
| Reuters | $213.26 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Conexeu Sciences Inc. Common Stock
Conexeu Sciences Inc. develops collagen-based regenerative tissue scaffold products for applications in medical aesthetics and tissue repair. The company provides patented collagen-based scaffold products, including a collagen extracellular matrix (ECM) scaffold platform for use in medical aesthetics, wound care, tissue repair, facial rejuvenation, and large-volume body contouring such as face, b… Read more